REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Sinovac Biotech Ltd. (Antigua and Barbuda)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Sinovac Biotech Ltd. Profile Updated: July 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

The Company was founded on March 1, 1999 in Antigua. The Company is related to research, development, manufacture, and marketing of vaccines that protect against human infectious diseases. The Company is listed on the NASDAQ Stock Exchange.

Headquarters
No. 39 Shangdi Xi Road, Haidian District
Beijing; Beijing; Postal Code: 100085

Contact Details: Purchase the Sinovac Biotech Ltd. report to view the information.

Website: http://www.sinovac.com

Basic Information
Total Employees:
Purchase the Sinovac Biotech Ltd. report to view the information.
Outstanding Shares:
Purchase the Sinovac Biotech Ltd. report to view the information.
Financial Auditors:
Purchase the Sinovac Biotech Ltd. report to view the information.
Incorporation Date:
1999
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Vice Chief Executive Officer
Purchase this report to view the information.
Vice Chairman of the Supervisory Board
Ownership Details
Purchase this report to view the information.
18.87%
Purchase this report to view the information.
11%
Purchase this report to view the information.
10.33%
Purchase this report to view the information.
10.33%
Purchase this report to view the information.
5.25%
Subsidiaries
Sinovac Biomed Co., Ltd. (China)
100%
Sinovac Biotech Co., Ltd. (China)
73.09%
Sinovac Life Sciences Co., Ltd. (China)
59.24%
Company Performance
Financial values in the chart are available after Sinovac Biotech Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-13.58%▼
Total operating revenue
104.86%▲
Operating profit (EBIT)
-16.43%▼
Net Profit (Loss) for the Period
-128.71%▼
Total assets
-6.03%▼
Total equity
-5.97%▼
Operating Profit Margin (ROS)
-22.89%▼
Net Profit Margin
-35.19%▼
Return on Equity (ROE)
-0.35%▼
Debt to Equity Ratio
0.92%▲
Quick Ratio
1.5%▲
Cash Ratio
-0.29%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo